Episode 194 -- Anti-Corruption Trends in the Pharmaceutical and Medical Device Industries

Michael Volkov
The Justice Department and the SEC have a long history of focusing FCPA enforcement on pharmaceutical and medical device companies. Starting with a broad "industry sweep" nearly a decade ago, DOJ and the SEC have brought numerous enforcement actions. In response, drug and device companies have attempted to implement effective compliance programs.

In this Episode, Mike Volkov discusses FCPA enforcement trends and compliance strategies.


Other MultiMedia by The Volkov Law Group

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Michael Volkov, The Volkov Law Group | Attorney Advertising

Written by:

Michael Volkov

The Volkov Law Group on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.